- Home
- ACEL vs GHRS Comparison
ACEL vs GHRS Comparison
Compare ACEL & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACEL
- GHRS
- Stock Information
- Founded
- ACEL 2009
- GHRS 2018
- Country
- ACEL United States
- GHRS Ireland
- Employees
- ACEL N/A
- GHRS N/A
- Industry
- ACEL Services-Misc. Amusement & Recreation
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- ACEL Consumer Discretionary
- GHRS Health Care
- Exchange
- ACEL Nasdaq
- GHRS Nasdaq
- Market Cap
- ACEL 883.4M
- GHRS 774.1M
- IPO Year
- ACEL N/A
- GHRS 2021
- Fundamental
- Price
- ACEL $10.14
- GHRS $13.59
- Analyst Decision
- ACEL Buy
- GHRS Strong Buy
- Analyst Count
- ACEL 1
- GHRS 9
- Target Price
- ACEL $16.00
- GHRS $29.33
- AVG Volume (30 Days)
- ACEL 320.0K
- GHRS 311.3K
- Earning Date
- ACEL 11-04-2025
- GHRS 11-07-2025
- Dividend Yield
- ACEL N/A
- GHRS N/A
- EPS Growth
- ACEL N/A
- GHRS N/A
- EPS
- ACEL 0.50
- GHRS N/A
- Revenue
- ACEL $1,307,029,000.00
- GHRS N/A
- Revenue This Year
- ACEL $9.91
- GHRS N/A
- Revenue Next Year
- ACEL $4.73
- GHRS N/A
- P/E Ratio
- ACEL $20.26
- GHRS N/A
- Revenue Growth
- ACEL 7.97
- GHRS N/A
- 52 Week Low
- ACEL $9.02
- GHRS $6.72
- 52 Week High
- ACEL $13.28
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- ACEL 41.49
- GHRS 50.43
- Support Level
- ACEL $9.82
- GHRS $12.50
- Resistance Level
- ACEL $10.58
- GHRS $14.77
- Average True Range (ATR)
- ACEL 0.23
- GHRS 0.95
- MACD
- ACEL -0.00
- GHRS -0.00
- Stochastic Oscillator
- ACEL 42.11
- GHRS 50.21
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.